- Home
- VKI vs ANGO Comparison
VKI vs ANGO Comparison
Compare VKI & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VKI | ANGO |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 406.3M | 462.0M |
| IPO Year | 1994 | 2004 |
Fundamental Metrics
Financial Performance| Metric | VKI | ANGO |
|---|---|---|
| Price | $9.32 | $10.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 147.1K | ★ 343.2K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $7.89 | $8.27 |
| 52 Week High | $9.45 | $13.99 |
Technical Indicators
Market Signals| Indicator | VKI | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 61.21 | 47.38 |
| Support Level | $8.66 | $10.37 |
| Resistance Level | N/A | $11.03 |
| Average True Range (ATR) | 0.11 | 0.38 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 61.29 | 22.55 |
Price Performance
Historical ComparisonAbout VKI Invesco Advantage Municipal Income Trust II of Beneficial Interest (DE)
Invesco Advantage Municipal Income Trust II is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.